Under pathological conditions, including as a consequence of neurodegeneration, differential expression of the 3R and 4R tau isoforms is observed across different brain regions, and depending on the predominance of the isoform, may confer any one of several distinct tauopathies, including in AD.17, 18, 19, 20, 21. The gene discussed is MAPT; the disease is Alzheimer disease.